motega health


Motega Health is dedicated to inventing better health solutions through advanced oral mucosal technologies and innovative drug delivery systems. With a team experienced in human and animal pharmaceutical development, the company aims to make medications easier to take and more effective, addressing challenges such as drug metabolism issues, swallowing difficulties, and patent expirations. They offer a pipeline of ready-to-license products and technologies across pharma, nutraceuticals, veterinary, and food spaces, striving to improve quality of life globally.

Industries

health-care
pharmaceutical

Nr. of Employees

small (1-50)

motega health

Lawrence, Kansas, United States, North America


Products

Oral testosterone formulation

An orally administered testosterone formulation designed for systemic absorption via the oral mucosa to provide bioidentical testosterone without hepatotoxicity concerns.

Nicotine replacement system

A semi-liquid, water-repellent mucosal delivery system that adheres to oral mucosa to transfer nicotine to the bloodstream for rapid onset and extended action up to ~2 hours.

Vaginal pseudoplastic formulation

Vaginal formulation engineered with pseudoplastic rheology to ensure 12–24 hour retention and compatibility across pH, APIs, and contraceptive use cases.


Services

Licensing and technology transfer

Licensing of proprietary delivery technologies and ready-to-license product candidates to commercial partners.

Formulation and pharmaceutical delivery development consulting

Contract development services for formulation design (oral mucosal, sustained release, injectables, topicals) and product optimization.

Vaccine adjuvant and enteric coating development

Development support for vaccine adjuvant formulations and enteric coating solutions to control site-of-release.

Expertise Areas

  • Drug delivery platform development
  • Formulation development across oral, topical, injectable, and mucosal routes
  • Sustained and targeted release technologies
  • Oral mucosal (buccal) delivery
  • Show More (4)

Key Technologies

  • Oral mucosal drug delivery
  • Controlled / sustained release formulations
  • Pseudoplastic rheology formulations (vaginal retention)
  • Semi-liquid and semi-solid dosage forms
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.